The efficacy and safety of <scp>ISIS</scp> 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase <scp>II</scp> study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study

Published:2024-08-19 Issue: Volume: Page:
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Ji Linong¹^ORCID,Gao Leili¹^ORCID,Feng Zhikai²,Chen Guoliang²^ORCID,Fu Jing²,Morgan Erin³,Bhanot Sanjay³,Gao Shan²,Zhang Hongyan²,Liang Zicai²,Gan Li‐Ming²⁴⁵⁶

Affiliation:

1. Department of Endocrinology and Metabolism Peking University People's Hospital Beijing China

2. Suzhou Ribo Life Science Co. Ltd Suzhou China

3. Ionis Pharmaceuticals Carlsbad California USA

4. Ribocure Pharmaceuticals AB Gothenburg Sweden

5. Department of Cardiology Sahlgrenska University Hospital Gothenburg Sweden

6. Department of Molecular and Clinical Medicine, Institute of Medicine Sahlgrenska Academy at the University of Gothenburg Gothenburg Sweden

Publisher

Wiley

Reference11 articles.

1. Diabetes Mellitus Review;Blair M;Urol Nurs,2016

2. Epidemiology of diabetes and diabetic complications in China;Ma RCW;Diabetologia,2018

3. Glucagon potentiates insulin secretion via beta‐cell GCGR at physiological concentrations of glucose;Zhang Y;Cells,2021

4. The past, present, and future physiology and pharmacology of glucagon;Capozzi ME;Cell Metab,2022

5. Glucagon receptor as a drug target: a witches' brew of eye of newt (peptides) and toe of frog (receptors);Nunez DJ;Diabetes Obes Metab,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP